Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Clinical Trials: Overview01:11

Clinical Trials: Overview

4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

409
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
409
Clinical Trials01:16

Clinical Trials

10.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.4K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

95.4K
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
95.4K
Uncertainty in Measurement: Accuracy and Precision03:37

Uncertainty in Measurement: Accuracy and Precision

101.1K
Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value. 
101.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Managing asymmetry in bicuspid aortic valve repair: A case-based illustration.

JTCVS structural and endovascular·2026
Same author

Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Propensity-matched analysis of the impact of saphenous vein graft external stenting on clinical outcomes in coronary bypass surgery: The RESTART study.

JTCVS open·2025
Same author

Hybrid Revascularization Approach Using Robot-Assisted Bilateral Internal Mammary Artery Grafting.

Brazilian journal of cardiovascular surgery·2025
Same author

Time to Assess the Role of Quality Control in CABG: The SMARTFLOW Trial Program.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2025
Same author

Mechanistic classification of isolated severe aortic regurgitation in a contemporary cohort of patients.

European heart journal open·2025
Same journal

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

A Bundle to Frame Guidelines and American Heart Association Statements.

Circulation·2026
Same journal

<i>Circulation</i> Editors and Editorial Board.

Circulation·2026
Same journal

A New <i>Circulation</i>, For You.

Circulation·2026
Same journal

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026
Same journal

Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023.

Circulation·2026
関連記事をすべて見る

関連する実験動画

Updated: Jan 31, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

心筋再血管化試験

Marc Ruel1, Volkmar Falk2, Michael E Farkouh3

  • 1University of Ottawa Heart Institute, University of Ottawa, Canada (M.R., D.G.).

Circulation
|December 20, 2018
PubMed
まとめ
この要約は機械生成です。

最近の臨床試験では,PCIと冠動脈バイパス移植 (CABG) を比較し,PCIの利点を過大評価している. 証拠の慎重な解釈と改善された試験設計は,将来の研究のために推奨されます.

キーワード:
臨床試験のテーマとして冠動脈疾患冠動脈狭窄症経皮冠動脈介入手術の手続き,手術治療の結果

さらに関連する動画

Induction of Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury in Mice
08:28

Induction of Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury in Mice

Published on: January 19, 2022

8.3K
Ultrasonic Assessment of Myocardial Microstructure
10:53

Ultrasonic Assessment of Myocardial Microstructure

Published on: January 14, 2014

5.9K

関連する実験動画

Last Updated: Jan 31, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Induction of Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury in Mice
08:28

Induction of Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury in Mice

Published on: January 19, 2022

8.3K
Ultrasonic Assessment of Myocardial Microstructure
10:53

Ultrasonic Assessment of Myocardial Microstructure

Published on: January 14, 2014

5.9K

科学分野:

  • 心血管医学
  • 介入心臓科
  • 心臓外科

背景:

  • 経皮冠動脈干渉 (PCI) と冠動脈バイパス移植 (CABG) は,左主動脈および多血管冠動脈疾患の主要な再血管化戦略です.
  • 最近の研究では,PCIとCABGの有効性と安全性を比較し,複雑で時には議論の余地のある結果が得られました.

研究 の 目的:

  • PCIとCABGを比較した最近の心筋再血管化試験の証拠を批判的に検討する.
  • 試験設計,患者選択,および結果の解釈に影響を与える可能性のあるバイアスを分析する.
  • 現在の証拠を慎重に解釈し,将来の臨床試験の設計を推奨する.

主な方法:

  • 主要なランダム化対照試験から得られた公表されたデータの体系的なレビューと批判的評価.
  • 臨床試験の方法論の分析,患者の含有/排除の基準と結果の定義
  • 特定の患者のサブグループにおけるPCIとCABGの比較効果を評価するための証拠の統合.

主要な成果:

  • 特定の患者グループ (例えば,非糖尿病,低解剖学的複雑性) のPCIの主張された非劣等性は,試験の設計によって影響を受けることがあります.
  • PCIとエンドポイントの最適化を好む患者の選択は,CABGよりもPCIを好む結果に歪んだ可能性があります.
  • 特定の複雑な患者集団において,CABGは依然として優れた長期的な結果をもたらす可能性があるという証拠があります.

結論:

  • PCIとCABGを比較する現在の証拠を慎重に解釈することは正当である.
  • 将来の試験では 堅実な設計,偏見のない患者選択,比較効果を正確に反映するための適切なエンドポイントを優先すべきである.
  • 臨床試験の設計と実施における協力的な取り組みは,心血管介入の知識の進歩に不可欠です.